Identification of potential genes in endobronchial tuberculosis after bronchoscopic cryotherapy by transcriptome sequencing

Infect Genet Evol. 2022 Jun:100:105269. doi: 10.1016/j.meegid.2022.105269. Epub 2022 Mar 15.

Abstract

Background: Bronchoscopic cryotherapy facilitates the treatment of endobronchial tuberculosis (EBTB) and helps suppress progressive bronchial stenosis. However, the molecular mechanism of bronchoscopic cryotherapy in EBTB patients has not been reported.

Methods: Transcriptome sequencing was performed to explore differentially expressed mRNAs (DEGs) in EBTB patients before and after bronchoscopic cryotherapy. Gene Ontology (GO) and KEGG analyses were carried out. Five genes (MKLN1, HIGD1A, PTGES, SKIL, and MCEMP1) were selected and validated using real-time qPCR (RT- qPCR).

Results: In transcriptome analysis, 448 DEGs with p < 0.05 and|logFC| > 1 were identified; of these, 171 and 277 DEGs were significantly up- and down-regulated after bronchoscopic cryotherapy, respectively. Results displayed 337 biological process (GO-BP), 48 cellular component (GO-CC) and 62 molecular function (GO-MF) terms and 20 KEGG pathways. RT- qPCR results were consistent with the sequencing data.

Conclusion: These data provide informative evidence and recommendations for further scientific research on bronchoscopic cryotherapy for EBTB.

Keywords: Bronchoscopic cryotherapy; Differentially expressed mRNAs; Endobronchial tuberculosis; Transcriptome sequencing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bronchial Diseases* / genetics
  • Bronchial Diseases* / therapy
  • Cryotherapy
  • Gene Expression Profiling / methods
  • Humans
  • Transcriptome
  • Tuberculosis* / therapy